Document Detail


Mn-citrate and Mn-HIDA: intermediate-affinity chelates for manganese-enhanced MRI.
MedLine Citation:
PMID:  23281286     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
In this study we investigated two manganese chelates in order to improve the image enhancement of manganese-enhanced MRI and decrease the toxicity of free manganese ions. Since both MnCl(2) and a low-affinity chelate were associated with a slow continuous decrease of cardiac functions, we investigated intermediate-affinity chelates: manganese N-(2-hydroxyethyl)iminodiacetic acid (Mn-HIDA) and Mn-citrate. The T(1) relaxivity values for Mn-citrate (4.4 m m(-1) s(-1) ) and Mn-HIDA (3.3 m m(-1) s(-1) ) in artificial cerebrospinal fluid (CSF) were almost constant in a concentration range from 0.5 to 5 m m at 37 °C and 4.7 T. In human plasma, the relaxivity values increased when the concentrations of these Mn chelates were decreased, suggesting the presence of free Mn(2+) bound with serum albumin. Mn-HIDA and Mn-citrate demonstrated a tendency for better contractility when employed with an isolated perfused frog heart, compared with MnCl(2) . Only minimal changes were demonstrated after a venous infusion of 100 m m Mn-citrate or Mn-HIDA (8.3 µmol kg(-1) min(-1) ) in rats and a constant heart rate, arterial pressure and sympathetic nerve activity were maintained, even after breaking the blood-brain barrier (BBB). Mn-citrate and Mn-HIDA could not cross the intact BBB and appeared in the CSF, and then diffused into the brain parenchyma through the ependymal layer. The responses in the supraoptic nucleus induced by the hypertonic stimulation were detectable. Therefore, Mn-citrate and Mn-HIDA appear to be better choices for maintaining the vital conditions of experimental animals, and they may improve the reproducibility of manganese-enhanced MRI of the small nuclei in the hypothalamus and thalamus. Copyright © 2012 John Wiley & Sons, Ltd.
Authors:
Yoshiteru Seo; Keitaro Satoh; Hironobu Morita; Akira Takamata; Kazuto Watanabe; Takashi Ogino; Tooru Hasebe; Masataka Murakami
Related Documents :
1143356 - Influence of spironolactone pretreatment on pharmacokinetics and metabolism of digitoxi...
39996 - The disposition of [14c]metronidazole in rats following vaginal and oral administration.
15683156 - Tissue distribution and elimination of selected chlorinated naphthalenes.
21080136 - Lipopolysaccharide pretreatment protects against ischemia/reperfusion injury via increa...
7435606 - Central site for pressor action of blood-borne angiotensin in rat.
9622456 - Altered t-lymphocyte responsiveness to polyclonal cell activators is responsible for li...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Contrast media & molecular imaging     Volume:  8     ISSN:  1555-4317     ISO Abbreviation:  Contrast Media Mol Imaging     Publication Date:  2013 Mar 
Date Detail:
Created Date:  2013-01-02     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101286760     Medline TA:  Contrast Media Mol Imaging     Country:  United States    
Other Details:
Languages:  eng     Pagination:  140-6     Citation Subset:  IM    
Copyright Information:
Copyright © 2012 John Wiley & Sons, Ltd.
Affiliation:
Department of Regulatory Physiology, Dokkyo Medical University School of Medicine, Tochigi, 321-0293, Japan. yseo@dokkyomed.ac.jp.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A dual magnetic resonance imaging/fluorescent contrast agent for Cathepsin-D detection.
Next Document:  Concentrations of Gd-BOPTA in cholestatic fatty rat livers: role of transport functions through memb...